» Articles » PMID: 25599074

Validation of a Patient Reported Outcome Questionnaire for Assessing Success of Endoscopic Prostatectomy

Overview
Journal Prostate Int
Date 2015 Jan 20
PMID 25599074
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Several international committees involved in establishing standards of care have recommended that patients undergoing surgery for bladder outlet obstruction should be assessed with patient reported outcomes (PRO). The Patient Global Impression of Improvement (PGI-I) is an instrument designed to measure a patients interpretation of symptom changes following intervention. The objective of this study was to validate the PGI-I as a PRO assessment following surgery for bladder outflow obstruction (BOO) in men with benign prostatic hyperplasia (BPH).

Methods: Men undergoing photoselective vaporisation of the prostate were followed prospectively. Pre- and postoperative International Prostate Symptom Score (IPSS), Quality of life (QoL) index, peak urinary flow (Qmax), and postvoid residual (PVR) assessments were done. The PGI-I was conducted and correlated at 3 months postoperatively to changes in IPSS, QoL, Qmax, and PVR.

Results: One hundred and sixty-six consecutive patients were included. Following surgery, IPSS and QoL improved by 11 and 2.4 points (P<0.0001). PGI-I was found to correlate with postoperative changes in IPSS and QoL (Pearson correlation, 0.47 and 0.58, respectively; P<0.0001).

Conclusions: This is the first study to validate the PGI-I as a PRO measure to surgery for BOO. This suggests a potential for the PGI-I to be used to assess surgical therapies for BPH and may be a valuable addition for measuring outcomes in clinical trials evaluating surgical interventions for BPH.

Citing Articles

Patient reported outcome and quality of life measured by a simple questionnaire in patients with symptomatic benign prostate hyperplasia treated by holmium laser enucleation of the prostate (HoLEP).

Schumacher S, Marghawal D, Brunken C, Herzberg J Front Surg. 2024; 11:1358701.

PMID: 38389860 PMC: 10881724. DOI: 10.3389/fsurg.2024.1358701.


Efficacy and safety profile of GreenLight laser photoselective vaporization of the prostate in ≥ 75 years old patients: results from the Italian GreenLight Laser Study Group.

Campobasso D, Morselli S, Greco F, De Nunzio C, Destefanis P, Fasolis G Aging Clin Exp Res. 2023; 35(4):877-885.

PMID: 36763245 DOI: 10.1007/s40520-023-02351-9.


Double blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial design.

McLaughlin N, Dougherty D, Eskandar E, Ward H, Foote K, Malone D Contemp Clin Trials Commun. 2021; 22:100785.

PMID: 34189335 PMC: 8219641. DOI: 10.1016/j.conctc.2021.100785.


Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase 2 Randomized Controlled Study.

Tatsuoka Y, Takeshima T, Ozeki A, Matsumura T Neurol Ther. 2021; 10(1):265-278.

PMID: 33835383 PMC: 8140173. DOI: 10.1007/s40120-021-00236-5.


The Value of FENO Measurement for Predicting Treatment Response in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Zhou A, Zhou Z, Deng D, Zhao Y, Duan J, Cheng W Int J Chron Obstruct Pulmon Dis. 2020; 15:2257-2266.

PMID: 33061343 PMC: 7522317. DOI: 10.2147/COPD.S263673.


References
1.
Yalcin I, Bump R . Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol. 2003; 189(1):98-101. DOI: 10.1067/mob.2003.379. View

2.
Mahajan S, Elkadry E, Kenton K, Shott S, Brubaker L . Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery. Am J Obstet Gynecol. 2006; 194(3):722-8. DOI: 10.1016/j.ajog.2005.08.043. View

3.
Irwin D, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S . Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006; 50(6):1306-14. DOI: 10.1016/j.eururo.2006.09.019. View

4.
McVary K, Roehrborn C, Avins A, Barry M, Bruskewitz R, Donnell R . Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011; 185(5):1793-803. DOI: 10.1016/j.juro.2011.01.074. View

5.
Kelleher C, Pleil A, Reese P, Burgess S, Brodish P . How much is enough and who says so?. BJOG. 2004; 111(6):605-12. DOI: 10.1111/j.1471-0528.2004.00129.x. View